Society of Hematologic Oncology Insider news

Dr. Roberto Mina on the pivotal phase 3 MajesTEC-9 trial in multiple myeloma

5 min · 5 de jun de 2026
Portada del episodio Dr. Roberto Mina on the pivotal phase 3 MajesTEC-9 trial in multiple myeloma

Descripción

In this SOHO Insider podcast, host Saad Usmani, MD, chief of the myeloma service at Memorial Sloan Kettering Cancer Center, spoke with Roberto Mina, MD, associate professor of hematology at Emory University, on news from the 2026 ASCO Annual Meeting. The conversation highlighted a presentation by Dr. Roberto Mina regarding the pivotal phase 3 MajesTEC-9 trial evaluating teclistamab monotherapy for patients with relapsed/refractory multiple myeloma who were previously exposed to lenalidomide and anti-CD38 antibodies Follow more news from ASCO here.  [https://sohoinsider.com/category/meetings-conferences/asco-2026/]

Comentarios

0

Sé la primera persona en comentar

¡Regístrate ahora y únete a la comunidad de Society of Hematologic Oncology Insider news!

Prueba gratis

Empieza 7 días de prueba

$99 / mes después de la prueba. · Cancela cuando quieras.

  • Podcasts solo en Podimo
  • 20 horas de audiolibros al mes
  • Podcast gratuitos

Todos los episodios

15 episodios

episode Dr. Nirav Shah on the next iteration in CAR-T cell therapy in blood cancer artwork

Dr. Nirav Shah on the next iteration in CAR-T cell therapy in blood cancer

In this SOHO Insider podcast, host Megan Melody, MD, from Tampa General Hospital, spoke with Nirav Shah, MD, professor at the Medical College of Wisconsin, on news from the 2026 Tandem Meetings, including updates on dual-targeted CAR T-cell results in CLL and interim phase 2 data on zamtocabtagene autoleucel (zamto-cel) in in transplant-ineligible patients with DLBCL. Of dual-targeting CAR-T cell therapies, he said, “I think this is the next iteration in CAR. Zamtocabtagene is one of four 20/19 CARs under development and if you look at the data for all of them, they look to be highly efficacious, better than our standard CD19-CAR.” Listen to more podcasts on sohoinsider.com.  [https://sohoinsider.com/category/soho-insider-podcast/]

7 de may de 202615 min
episode Why clinicians should lead hospitals, according to Prof. Amanda Goodall artwork

Why clinicians should lead hospitals, according to Prof. Amanda Goodall

Prof. Amanda Goodall, director of the Executive Master’s in Medical Leadership (EMML), a specialized MSc degree from Bayes Business School offering advanced leadership training to medical doctors, joined SOHO Insider podcast host Prof. Christopher Fox, a professor of hematology at Nottingham University Hospitals NHS Trust, for a discussion on expert leadership in healthcare. According to Prof. Goodall, expert leadership is the idea that organizations perform best when leaders are experts in the core work of the institution. As part of this work, she runs an executive master’s program in medical leadership, designed to help physicians develop the skills needed to lead healthcare organizations while maintaining credibility as clinicians. Her research argues that in healthcare this means placing experienced, high-performing physicians in leadership roles rather than relying primarily on generalist managers. Many doctors, she noted, are interested in leadership because they want to drive meaningful change and improve patient care, but historically they have had limited access to formal leadership training. The podcast was taped during the inaugural meeting of SOHO UK [https://sohoinsider.com/category/meetings-conferences/soho-uk/], where Prof. Goodall gave a talk after dinner on the topic. Learn about the Executive Master’s in Medical Leadership (EMML) program [https://www.bayes.citystgeorges.ac.uk/study/degree-apprenticeships/executive-msc-in-medical-leadership].

10 de mar de 20266 min